Ad
related to: community acquired pneumonia treatment in elderly- CABP Patient Types
See if your patients could be
eligible for this treatment.
- Pharmacy Network Finder
Use the finder to locate
pharmacies that carry our drug
- ABSSSI Patient Types
See if your patients could be
eligible for this treatment.
- Affordability
Learn about our services that
may help with access barriers.
- CABP Patient Types
Search results
Results from the WOW.Com Content Network
Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person outside of the healthcare system. In contrast, hospital-acquired pneumonia (HAP) is seen in patients who have recently visited a hospital or who live in long-term care facilities.
In 2018 AHRQ presented a new toolkit on the basis of CURB-65, an older counterpart to the PSI. [6] In the 2019 ATS/IDSA Guidelines for the Diagnosis and Treatment of Adults with Community-acquired Pneumonia, PSI was recommended over CURB-65 because of lack of evidence supporting the safety and effectiveness of the latter. [7]
Pneumonia is most commonly classified by where or how it was acquired: community-acquired, aspiration, healthcare-associated, hospital-acquired, and ventilator-associated pneumonia. [42] It may also be classified by the area of the lung affected: lobar, bronchial pneumonia and acute interstitial pneumonia ; [ 42 ] or by the causative organism ...
Pneumonia occurs in a variety of situations and treatment must vary according to the situation. [11] It is classified as either community or hospital acquired depending on where the patient contracted the infection. It is life-threatening in the elderly or those who are immunocompromised.
Hospital-acquired pneumonia, also called nosocomial pneumonia, is pneumonia acquired during or after hospitalization for another illness or procedure with onset at least 72 hrs after admission. The causes, microbiology, treatment and prognosis are different from those of community-acquired pneumonia.
Solithromycin (trade name Solithera) is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia [1] and other infections. [2] Solithromycin exhibits excellent in vitro activity against a broad spectrum of Gram-positive respiratory tract pathogens, [3] [4] including macrolide-resistant strains. [5]
Streptococcus pneumoniae is the main cause of community acquired pneumonia and meningitis in children and the elderly, [5] and of sepsis in those infected with HIV. The organism also causes many types of pneumococcal infections other than pneumonia.
Pneumococcal pneumonia is a type of bacterial pneumonia that is caused by Streptococcus pneumoniae (pneumococcus). [1] It is the most common bacterial pneumonia found in adults, the most common type of community-acquired pneumonia, and one of the common types of pneumococcal infection. The estimated number of Americans with pneumococcal ...
Ad
related to: community acquired pneumonia treatment in elderly